Table 5.
Association between intellectual disability and bowel cancer specific survival
| No ID (deaths / total) | ID (deaths / total) | 1-year (no ID) | 1-year (ID) | 3-year (no ID) | 3-year (ID) | HR (95% CI) | |
|---|---|---|---|---|---|---|---|
| All | 2015 / 6085 | 176 / 381 | 80.1% (79.1–81.1) | 63.1% (57.8–68.0) | 66.6% (65.3–67.9) | 47.6% (41.7–53.3) | 2.00 (1.71-2.33) |
| Stages 1–2 | 162 / 1715 | 17 / 89 | 95.5% (94.4–96.5) | 91.3% (82.5–95.8) | 91.1% (89.5–92.5) | 75.1% (61.4–84.5) | 2.34 (1.40-3.90) |
| Stage 3 | 270 / 1179 | 19 / 69 | 90.3% (88.4–91.9) | 82.3% (69.3–90.1) | 75.6% (72.5–78.4) | 63.7% (47.1–76.4) | 2.13 (1.33-3.41) |
| Stage 4 | 748 / 1178 | 61 / 89 | 52.9% (49.8–56.0) | 32.0% (21.8–42.7) | 24.2% (21.2–27.3) | 19.5% (10.8–30.1) | 1.63 (1.25-2.13) |
| Unknown | 835 / 2013 | 79 / 134 | 76.1% (74.1–77.9) | 54.6% (45.6–62.7) | 63.7% (61.5–65.9) | 39.2% (30.3–48.0) | 2.27 (1.79-2.86) |
ID intellectual disability, HR hazard ratio, CI confidence interval